Paul Passier
Director Clinical Pharmacology @ Galapagos
Eindhoven, The Netherlands
Paul Passier is a startup investor at Galapagos in Eindhoven. Paul Passier - Director Clinical Pharmacology @ Galapagos
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
About Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
Galapagos Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andre Hoekema
Chief Business Officer
|
|||
Kruti Popat
Director, Customer Insights & Engagement
|
|||
Michele Manto
Chief Commercial Officer
|
|||
|
Paul Passier
Director Clinical Pharmacology
|
|||
Paul Stoffels
Chief Executive Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Paul Passier?
Public channels for Paul Passier include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
